Rachael Hunter

Has grant

Professor of Health Economics

University College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Randomised controlled trial of the Community Navigator programme to reduce loneliness and depression for adults with treatment resistant depression in secondary mental health services

Open Date: 2021-09-01

Close Date: 2025-02-28

Grant: Close

COmBining memantine And cholinesterase inhibitors in Lewy body dementia treatment Trial (COBALT)

Open Date: 2021-04-01

Close Date: 2025-09-30

Grant: Close

Anchored Muscle cELls for IncontinencE

Open Date: 2020-09-01

Close Date: 2025-08-31

Grant: Close

Clinical and cost-effectiveness of a personalised health promotion intervention enabling independence in older people with mild frailty (‘HomeHealth’): A Randomised Controlled Trial

Open Date: 2020-05-01

Close Date: 2023-04-30

Grant: Close

Personalised treatment packages for adults with learning disabilities who display aggression in community settings (PerTA-LD)

Open Date: 2020-04-01

Close Date: 2025-09-30

Articles (19)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (27)

Naomi Fulop

University College London

UNITED KINGDOM

Rachael Hunter

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (19)

Specialist physiotherapy for functional motor disorder in England and Scotland (Physio4FMD): a pragmatic, multicentre, phase 3 randomised controlled trial

Evaluating a model of best practice in primary care led post-diagnostic dementia care: feasibility and acceptability findings from the PriDem study

Feasibility Randomized Controlled Trial of Face-to-Face Counseling and Mobile Phone Messages Compared to Usual Care for Smokeless Tobacco Cessation in Indian Primary Care: Project CERTAIN

Is Economic Evaluation and Care Commissioning Focused on Achieving the Same Outcomes? Resource-Allocation Considerations and Challenges Using England as a Case Study

Whither Decision-Analytic Modelling-Based Economic Evaluation for Health Care Decision Making?

Does the cost of cancer care for people in prison differ from those in the general population? Analysis of matched English cancer registry and hospital records

Repeat Placental Growth Factor-Based Testing in Women With Suspected Preterm Preeclampsia: A Stratified Analysis of the PARROT-2 Trial

Clinical and cost-effectiveness of an adapted intervention for preschoolers with moderate to severe intellectual disabilities displaying behaviours that challenge: the EPICC-ID RCT

Centralisation of specialist cancer surgery services in two areas of England: the RESPECT-21 mixed-methods evaluation

The Cost-effectiveness of Improving the Timeliness of Endovascular Thrombectomy by Direct Access to Angiography

Excess Treatment Costs of Multiple Sclerosis

Cost-utility analysis of planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX)

Placental growth fActor Repeat sampling for Reduction of adverse perinatal Outcomes in women with suspecTed pre-eclampsia: study protocol for a randomised controlled trial (PARROT-2)

Economic evaluation of a complex intervention (Engager) for prisoners with common mental health problems, near to and after release: a cost-utility and cost-consequences analysis

A manualised weight management programme for adults with mild–moderate intellectual disabilities affected by excess weight: A randomised controlled feasibility trial (Shape Up-LD)*

Exploratory randomised trial of face-to-face and mobile phone counselling against usual care for tobacco cessation in Indian primary care: A randomised controlled trial protocol for project CERTAIN

Planned delivery for pre-eclampsia between 34 and 37 weeks of gestation: the PHOENIX RCT

Cost-Utility Analysis of Planned Early Delivery or Expectant Management for Late Preterm Pre-eclampsia (PHOENIX)

Two‐year follow‐up of infant and maternal outcomes after planned early delivery or expectant management for late preterm pre‐eclampsia (PHOENIX): A randomised controlled trial

Collaborators (27)

Naomi Fulop

Virginia Chiocchia

Pollyanna Hardy

Andrew Shennan

Laura Vallejo Torres

Elizabeth Davies

Glenn Nielsen

Jenny Myers

Rumana Omar

Georgia Black

Louise Marston

Jon Stone

Federica D'Andrea

Mark Haddad

Gareth Ambler

Kate Duhig

Fiona Warren

Jo Armes

Charlotte Lennox

Matthew Franklin

Phillippa Lally

Caroline Clarke

Lewis Benjamin

Angus Ramsay

Laura Goldstein

Emily Spencer

Irwin Nazareth

Make your next move.